Actinium Pharmaceuticals, Inc.
(NYSE Amex Equities : ATNM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -0.91%75.241.0%$2009.70m
AMGNAmgen, Inc. -1.94%204.451.3%$926.20m
REGNRegeneron Pharmaceuticals, Inc. -0.21%472.012.6%$800.61m
BIIBBiogen, Inc. -0.25%315.341.5%$749.71m
VRTXVertex Pharmaceuticals, Inc. 1.85%236.221.9%$574.76m
MRNAModerna, Inc. -1.63%29.980.0%$553.41m
ILMNIllumina, Inc. -1.22%272.883.5%$472.48m
ALXNAlexion Pharmaceuticals, Inc. 2.17%89.152.0%$284.67m
AAgilent Technologies, Inc. -1.07%71.891.6%$234.15m
EXASEXACT Sciences Corp. -0.34%58.2321.0%$199.97m
INCYIncyte Corp. 1.57%73.302.5%$179.50m
SGENSeattle Genetics, Inc. 1.37%116.876.1%$172.04m
BMRNBioMarin Pharmaceutical, Inc. 3.09%85.044.3%$165.84m
NVAXNovavax, Inc. -2.66%13.92114.7%$129.97m
ALNYAlnylam Pharmaceuticals, Inc. 1.72%110.708.7%$103.08m

Company Profile

Actinium Pharmaceuticals, Inc. is a clinical-stage, Biopharmaceutical Company focused on developing and potentially commercializing therapies to cell therapies. The firm's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells. Its product pipeline includes Iomab-B, Actimab-A, and Actimab-M. The company was founded in 1993 and is headquartered in New York, NY.